ESR1 and breast cancer: Estrogenic ligands regulate the expression and stability of ERα and ERβ in BC through diverse molecular mechanisms depending on the conformation change elicited in the ER subtypes (Pink and Jordan, 1996; Khissiin and Leclercq, 1999; Wijayaratne and McDonnell, 2001).